Celldex Therapeutics Presents Positive 12 Week Results from

- Primary and secondary endpoints met with clinically meaningful and statistically significant decreases in urticaria disease activity across multiple dose...

Related Keywords

United States , Berlin , Germany , American , Anthonys Marucci , Marcus Maurer , Sarah Cavanaugh , Allen Kaplan , Nasdaq , American Academy Of Allergy , Corporate Affairs Administration , Company Phase , Company Contact , Celldex Therapeutics Inc , Celldex Therapeutics , American Academy , Annual Meeting , Chief Executive Officer , Clinical Activity Assessments , Confidence Interval , Complete Control , Private Securities Litigation Reform Act , Vice President , Corporate Affairs , Nasdaq Cldx , Nc ,